{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T14:35:39Z","timestamp":1784039739381,"version":"3.55.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ministry of Science, Sport and Education","award":["214-0000000-3573"],"award-info":[{"award-number":["214-0000000-3573"]}]},{"name":"Ministry of Science, Sport and Education","award":["214-0000000-3354"],"award-info":[{"award-number":["214-0000000-3354"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.humimm.2016.11.010","type":"journal-article","created":{"date-parts":[[2016,12,18]],"date-time":"2016-12-18T08:17:50Z","timestamp":1482049070000},"page":"95-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["The impact of KIR2DS4 gene on clinical outcome after hematopoietic stem cell transplantation"],"prefix":"10.1016","volume":"78","author":[{"given":"Marija","family":"Burek Kamenaric","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Stingl Jankovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zorana","family":"Grubic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranka","family":"Serventi Seiwerth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marija","family":"Maskalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damir","family":"Nemet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirta","family":"Mikulic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Zunec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2016.11.010_b0005","doi-asserted-by":"crossref","first-page":"216","DOI":"10.5045\/kjh.2011.46.4.216","article-title":"Human diversity of killer cell immunoglobulin-like receptors and disease","volume":"46","author":"Rajalingam","year":"2011","journal-title":"Korean J. Hematol."},{"key":"10.1016\/j.humimm.2016.11.010_b0010","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1182\/blood-2006-07-038687","article-title":"Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value","volume":"110","author":"Ruggeri","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2016.11.010_b0015","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1182\/blood-2008-01-132902","article-title":"The reactivity of Bw4 + HLA-B and HLA-A alleles with KIR3DL1: implications for patient and donor suitability for haploidentical stem cell transplantations","volume":"112","author":"Foley","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2016.11.010_b0020","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1038\/sj.leu.2403839","article-title":"A defined donor activating natural killer cell receptor genotype protects against leukemic relapse after related HLA-identical hematopoietic stem cell transplantation","volume":"19","author":"Verheyden","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.humimm.2016.11.010_b0025","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1084\/jem.20091010","article-title":"KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C","volume":"206","author":"Graef","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.humimm.2016.11.010_b0030","doi-asserted-by":"crossref","first-page":"4878","DOI":"10.1182\/blood-2004-12-4825","article-title":"Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes","volume":"105","author":"Hsu","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2016.11.010_b0035","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.coi.2009.07.015","article-title":"Natural killer cell allorecognition of missing self in allogeneic hematopoietic transplantation: a tool for immunotherapy of leukemia","volume":"21","author":"Velardi","year":"2009","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.humimm.2016.11.010_b0040","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1182\/blood-2011-01-329508","article-title":"Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients","volume":"118","author":"Curti","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2016.11.010_b0045","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.humimm.2013.04.028","article-title":"Distribution of KIR genes in the Croatian population","volume":"74","author":"Burek","year":"2013","journal-title":"Hum. Immunol."},{"issue":"28","key":"10.1016\/j.humimm.2016.11.010_b0050","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/nar\/gku1166","article-title":"Allele frequency net 205 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations","volume":"2015","author":"Gonzalez-Galarza","year":"2015","journal-title":"Nucl. Acid Res."},{"key":"10.1016\/j.humimm.2016.11.010_b0055","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1084\/jem.20051884","article-title":"Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function","volume":"203","author":"Yawata","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.humimm.2016.11.010_b0060","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1399-0039.2005.00412.x","article-title":"Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population","volume":"65","author":"Jiang","year":"2005","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.humimm.2016.11.010_b0065","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/j.molimm.2007.11.014","article-title":"Activating KIRs exert a crucial role on relapse and overall survival after HLA-identical sibling transplantation","volume":"45","author":"Schellekens","year":"2008","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.humimm.2016.11.010_b0070","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1600-0609.2009.01280.x","article-title":"Activating killer immunoglobulin-like receptor incompatibilities enhance graft-versus-host disease and affect survival after allogeneic hematopoietic stem cell transplantation","volume":"83","author":"Giebel","year":"2009","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.humimm.2016.11.010_b0075","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.bbmt.2010.03.004","article-title":"Donor KIR genes 2DL5A, 2DS1 and 3DS1 are associated with a reduced rate of leukemia relapse after HLA-identical sibling stem cell transplantation for acute myeloid leukemia but not other hematologic malignancies","volume":"16","author":"Stringaris","year":"2010","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.humimm.2016.11.010_b0080","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1182\/blood-2009-08-236943","article-title":"Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation","volume":"115","author":"Venstrom","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2016.11.010_b0085","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1056\/NEJMoa1200503","article-title":"HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1","volume":"367","author":"Venstrom","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.humimm.2016.11.010_b0090","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1182\/blood-2010-10-313791","article-title":"Novel associations between activating killer-cell immunoglobulin-like receptor genes and childhood leukemia","volume":"118","author":"Almalte","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2016.11.010_b0095","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1182\/blood-2014-09-599993","article-title":"Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality","volume":"125","author":"Mancusi","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2016.11.010_b0100","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.mgene.2014.09.008","article-title":"KIR genotype distribution among patients with multiple myeloma: higher prevalence of KIR2DS4 and KIR2DS5 genes","volume":"2","author":"Hoteit","year":"2014","journal-title":"Meta Gene"},{"key":"10.1016\/j.humimm.2016.11.010_b0105","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.leukres.2009.04.022","article-title":"Killer cell immunoglobulin-like receptor gene polymorphisms in patients with leukemia: possible association with susceptibility to the disease","volume":"34","author":"Zhang","year":"2010","journal-title":"Leuk. Res."},{"key":"10.1016\/j.humimm.2016.11.010_b0110","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.febslet.2011.04.061","article-title":"Human NK receptors: from the molecules to the therapy of high risk leukemias","volume":"585","author":"Moretta","year":"2011","journal-title":"FEBS Lett."},{"key":"10.1016\/j.humimm.2016.11.010_b0115","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1038\/bmt.2009.357","article-title":"The impact of KIR2DS4 alleles and the expression of KIR in the development of acute GVHD after unrelated allogeneic hematopoietic SCT","volume":"45","author":"Bao","year":"2010","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.humimm.2016.11.010_b0120","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/1471-2474-15-256","article-title":"Presence of the full-length KIR2DS4 gene reduces the chance of rheumatoid arthritis patients to respond to methotrexate treatment","volume":"15","author":"Majorczyk","year":"2014","journal-title":"BMC Musculoskelet. Disord."},{"key":"10.1016\/j.humimm.2016.11.010_b0125","first-page":"625","article-title":"Expression of killer cell inhibitor receptors on immunocompetent cells with relation to graft-versus-host disease after hematopoietic stem cell transplantation","volume":"11","author":"Duan","year":"2003","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.humimm.2016.11.010_b0130","doi-asserted-by":"crossref","first-page":"e44718","DOI":"10.1371\/journal.pone.0044718","article-title":"Killer immunoglobulin-like receptor (KIR) and HLA genotypes affect the outcome of allogeneic kidney transplantation","volume":"7","author":"Nowak","year":"2012","journal-title":"PLoS One"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885916304931?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885916304931?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T16:22:42Z","timestamp":1536164562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885916304931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0198885916304931"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2016.11.010","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of KIR2DS4 gene on clinical outcome after hematopoietic stem cell transplantation","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2016.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}